These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. LETTER TO THE EDITOR: A response to Wamai et al. de Camargo KR; Mendonça AL; Perrey C; Giami A Glob Public Health; 2015; 10(10):1252. PubMed ID: 26512626 [No Abstract] [Full Text] [Related]
25. Condoms and HIV transmission. Johnson AM N Engl J Med; 1994 Aug; 331(6):391-2. PubMed ID: 8028620 [No Abstract] [Full Text] [Related]
26. [Sexually transmissible infections of the anus and the rectum]. Sultan S Rev Prat; 2008 Oct; 58(16):1793-801. PubMed ID: 19143151 [TBL] [Abstract][Full Text] [Related]
27. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. Celum CL; Robinson NJ; Cohen MS J Infect Dis; 2005 Feb; 191 Suppl 1():S107-14. PubMed ID: 15627220 [TBL] [Abstract][Full Text] [Related]
28. HIV transmission and sexually transmitted infections. Hay P Clin Med (Lond); 2008 Jun; 8(3):323-6. PubMed ID: 18624048 [No Abstract] [Full Text] [Related]
29. Debating male circumcision for HIV prevention: a one-sided argument does not represent a legitimate 'controversy' analysis--reply to de Camargo et al. Wamai RG; Morris BJ; Bailey RC; Klausner JD; Boedicker MN Glob Public Health; 2015; 10(5-6):672-8. PubMed ID: 25742443 [No Abstract] [Full Text] [Related]
30. Acyclovir for prevention of HIV transmission. AIDS Alert; 2010 Apr; 25(4):43-4. PubMed ID: 20560189 [No Abstract] [Full Text] [Related]
31. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir. Tyring SK; Baker D; Snowden W J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186 [TBL] [Abstract][Full Text] [Related]
32. Making the circumcision controversy controversial: going meta and taking aim at the messenger(s): reply to Wamai et al. de Camargo KR; Mendonça AL; Perrey C; Giami A Glob Public Health; 2015; 10(5-6):667-71. PubMed ID: 25585047 [No Abstract] [Full Text] [Related]
33. Genital ulcer disease treatment policies and herpes. O'Farrell N; Moodley P Sex Transm Dis; 2011 Feb; 38(2):150. PubMed ID: 21209599 [No Abstract] [Full Text] [Related]
34. Animal models of viral sexually transmitted diseases. Miller CJ Am J Reprod Immunol; 1994 Jan; 31(1):52-63. PubMed ID: 8166948 [No Abstract] [Full Text] [Related]
36. Genital ulcer disease treatment policies and access to acyclovir in eight sub-Saharan African countries. Corbell C; Stergachis A; Ndowa F; Ndase P; Barnes L; Celum C Sex Transm Dis; 2010 Aug; 37(8):488-93. PubMed ID: 20539260 [TBL] [Abstract][Full Text] [Related]
37. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa. Vickerman P; Devine A; Foss AM; Delany-Moretlwe S; Mayaud P; Meyer-Rath G Sex Transm Dis; 2011 May; 38(5):401-9. PubMed ID: 21317689 [TBL] [Abstract][Full Text] [Related]
38. Scientists zero in on new HIV microbicides. Voelker R JAMA; 1995 Apr; 273(13):979-80. PubMed ID: 7897800 [No Abstract] [Full Text] [Related]
39. Modern management of genital ulcer disease-frappez fort et frappez vite. Lewis D Sex Transm Dis; 2010 Aug; 37(8):494-6. PubMed ID: 20539259 [No Abstract] [Full Text] [Related]
40. CDC: avoid preventive therapy for sexual risk. Centers for Disease Control and Prevention. AIDS Alert; 1996 Jul; 11(7):75-6. PubMed ID: 11363548 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]